GlassScriptPhysician profile
Robert Ermentrout
NPI 1124345376
$1,217.75
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $504 · 2021: $19.82 · 2022: $210 · 2023: $32.60 · 2024: $38.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $294.83 | 2020 | |
| Medtronic, INC. | $167.19 | 2022 | |
| Sirtex Medical INC | $142.09 | 2019 | |
| Biocompatibles, INC. | $134.66 | 2019 | |
| Medtronic Vascular, INC. | $123.73 | 2019 | |
| Terumo Medical Corporation | $110.64 | 2019-2020 | |
| Cardiva Medical, INC. | $87.02 | 2022-2024 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Abbvie INC. | $76.22 | 2020 | |
| Guerbet LLC | $19.82 | 2021 | |
| Philips North America LLC | $18.16 | 2020 | |
| Trisalus Life Sciences, INC. | $16.47 | 2020 | |
| Medline Industries LP | $15.30 | 2024 | |
| Meditrina | $11.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ermentrout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.